Obesity Clinical Trials: Beyond BMI

BMI has long been the gold standard in obesity research, but its limitations are becoming harder to ignore. With new clinical guidance and evolving definitions from global experts, sponsors are rethinking how obesity is diagnosed and evaluated in trials.

This webinar, led by two international experts, Dr. Scott Isaacs and Prof. Carel le Roux, will highlight the importance of moving beyond BMI to incorporate a range of biomarkers in clinical trials for obesity. This shift can enhance the accuracy of obesity diagnosis, facilitate precision medicine and improve the prevention and treatment of obesity-related diseases. The expert panel will consider the novel challenges and opportunities that these evolving questions present in addressing the urgent need for safe and effective therapies for persons living with obesity.